Prof. Vladimir Bezuglov is a pioneer in multi-target drug design concept based on natural organism friendly molecules and a key scientist in this area worldwide. He is the main co-inventor of Nitric Oxide research platform that is a core technology in Gurus.
Prof. Vladimir Bezuglov is responsible for Discovery research, Patenting, Intellectual drug design, Platform development, Synthesis of new molecules. He is a Co-Founder and CSO in Gurus BioPharm LLC since 2011 and Regeus LLC since 2016 that are Russian subsidiaries of Gurus BioPharm Inc.
Prof. Vladimir Bezuglov got D.Sc. degree in bioorganic chemistry in 1997 in Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry. He is Invited Professor in Lomonosov’ Moscow State University and Moscow Institute of Physics and Technology. He has above 205 papers in refereed journals, 6 monographs, 24 patents.